BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang YN, Lee HH, Hsu JL, Yu D, Hung MC. The impact of PD-L1 N-linked glycosylation on cancer therapy and clinical diagnosis. J Biomed Sci 2020;27:77. [PMID: 32620165 DOI: 10.1186/s12929-020-00670-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen LM, Chai JC, Liu B, Strutt TM, McKinstry KK, Chai KX. Prostasin regulates PD-L1 expression in human lung cancer cells. Biosci Rep 2021;41:BSR20211370. [PMID: 34240739 DOI: 10.1042/BSR20211370] [Reference Citation Analysis]
2 Rodrigues JG, Duarte HO, Reis CA, Gomes J. Aberrant protein glycosylation in cancer: implications in targeted therapy. Biochem Soc Trans 2021;49:843-54. [PMID: 33704376 DOI: 10.1042/BST20200763] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 De Vellis C, Pietrobono S, Stecca B. The Role of Glycosylation in Melanoma Progression. Cells 2021;10:2136. [PMID: 34440905 DOI: 10.3390/cells10082136] [Reference Citation Analysis]
4 Esmail S, Manolson MF. Advances in understanding N-glycosylation structure, function, and regulation in health and disease. Eur J Cell Biol 2021;100:151186. [PMID: 34839178 DOI: 10.1016/j.ejcb.2021.151186] [Reference Citation Analysis]
5 Tameishi M, Kobori T, Tanaka C, Urashima Y, Ito T, Obata T. Contribution of Ezrin on the Cell Surface Plasma Membrane Localization of Programmed Cell Death Ligand-1 in Human Choriocarcinoma JEG-3 Cells. Pharmaceuticals (Basel) 2021;14:963. [PMID: 34681187 DOI: 10.3390/ph14100963] [Reference Citation Analysis]
6 Gómez-Henao W, Tenorio EP, Sanchez FRC, Mendoza MC, Ledezma RL, Zenteno E. Relevance of glycans in the interaction between T lymphocyte and the antigen presenting cell. Int Rev Immunol 2021;40:274-88. [PMID: 33205679 DOI: 10.1080/08830185.2020.1845331] [Reference Citation Analysis]
7 Bailly C, Vergoten G. N-glycosylation and ubiquitinylation of PD-L1 do not restrict interaction with BMS-202: A molecular modeling study. Comput Biol Chem 2020;88:107362. [PMID: 32871472 DOI: 10.1016/j.compbiolchem.2020.107362] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
8 Zheng S, Song Q, Zhang P. Metabolic Modifications, Inflammation, and Cancer Immunotherapy. Front Oncol 2021;11:703681. [PMID: 34631531 DOI: 10.3389/fonc.2021.703681] [Reference Citation Analysis]
9 Maiorano BA, Maiorano MFP, Lorusso D, Maiello E. Ovarian Cancer in the Era of Immune Checkpoint Inhibitors: State of the Art and Future Perspectives. Cancers (Basel) 2021;13:4438. [PMID: 34503248 DOI: 10.3390/cancers13174438] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Rösner E, Kaemmerer D, Neubauer E, Sänger J, Lupp A. Prognostic value of PD-L1 expression in bronchopulmonary neuroendocrine tumours. Endocr Connect 2021;10:180-90. [PMID: 33475525 DOI: 10.1530/EC-20-0540] [Reference Citation Analysis]
11 Kobori T, Tanaka C, Tameishi M, Urashima Y, Ito T, Obata T. Role of Ezrin/Radixin/Moesin in the Surface Localization of Programmed Cell Death Ligand-1 in Human Colon Adenocarcinoma LS180 Cells. Pharmaceuticals (Basel) 2021;14:864. [PMID: 34577564 DOI: 10.3390/ph14090864] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zhu Y, Lin S, Wang Y, Shen B, Lin L, Wang L, He S. Study on PD-L1 Expression in NSCLC Patients and Related Influencing Factors in the Real World. Comput Math Methods Med 2021;2021:3273347. [PMID: 34992670 DOI: 10.1155/2021/3273347] [Reference Citation Analysis]
13 Hu X, Wang J, Chu M, Liu Y, Wang ZW, Zhu X. Emerging Role of Ubiquitination in the Regulation of PD-1/PD-L1 in Cancer Immunotherapy. Mol Ther 2021;29:908-19. [PMID: 33388422 DOI: 10.1016/j.ymthe.2020.12.032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Huang M, Zhu L, Kang S, Chen F, Wei X, Lin L, Chen X, Wang W, Zhu Z, Yang C, Song Y. In Situ Visualization of PD-L1-Specific Glycosylation on Tissue Sections. Anal Chem 2021;93:15958-63. [PMID: 34812034 DOI: 10.1021/acs.analchem.1c03287] [Reference Citation Analysis]
15 Tanaka C, Kobori T, Tameishi M, Urashima Y, Ito T, Obata T. Ezrin Modulates the Cell Surface Expression of Programmed Cell Death Ligand-1 in Human Cervical Adenocarcinoma Cells. Molecules 2021;26:5648. [PMID: 34577118 DOI: 10.3390/molecules26185648] [Reference Citation Analysis]
16 Lamberti G, Sisi M, Andrini E, Palladini A, Giunchi F, Lollini PL, Ardizzoni A, Gelsomino F. The Mechanisms of PD-L1 Regulation in Non-Small-Cell Lung Cancer (NSCLC): Which Are the Involved Players? Cancers (Basel) 2020;12:E3129. [PMID: 33114576 DOI: 10.3390/cancers12113129] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]